Carmell Corporation (CTCX)

NASDAQ: CTCX · Real-Time Price · USD
0.273
-0.006 (-2.26%)
At close: Nov 13, 2024, 4:00 PM
0.275
+0.003 (0.92%)
Pre-market: Nov 14, 2024, 8:51 AM EST
-2.26%
Market Cap 5.70M
Revenue (ttm) 12,320
Net Income (ttm) -14.93M
Shares Out 20.91M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 228,726
Open 0.270
Previous Close 0.279
Day's Range 0.261 - 0.285
52-Week Range 0.201 - 4.313
Beta 0.31
Analysts n/a
Price Target n/a
Earnings Date Nov 22, 2024

About CTCX

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physic... [Read more]

Founded 2007
Employees 10
Stock Exchange NASDAQ
Ticker Symbol CTCX
Full Company Profile

Financial Performance

Financial Statements

News

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman.

3 months ago - GlobeNewsWire

Carmell Announces Successful Closing of $3.0 Million Private Placement

PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

7 months ago - GlobeNewsWire

Carmell Announces $3.0 Million Private Placement

PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

8 months ago - GlobeNewsWire

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

PITTSBURGH, March 27, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

8 months ago - GlobeNewsWire

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

PITTSBURGH, March 20, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today anno...

8 months ago - GlobeNewsWire

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

PITTSBURGH, March 18, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced it will host a...

8 months ago - GlobeNewsWire

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

PITTSBURGH, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced that they have ...

9 months ago - GlobeNewsWire

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

PITTSBURGH, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a human biomaterials company (“Carmell”), today announced the addition of two independent directors to their Board.

1 year ago - GlobeNewsWire

Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine

FLAGSTAFF, Ariz. , Sept. 12, 2023 /PRNewswire/ -- Moonshot is excited to announce that its incubator client, Axolotl Biologix, based in its NACET Flagstaff, Arizona campus, has finalized a merger with...

1 year ago - PRNewsWire

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion of post-merger integration with Flagstaff-bas...

1 year ago - GlobeNewsWire

Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

PITTSBURGH & FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company today announced the successful closing of the previously announced merger wi...

1 year ago - Business Wire

Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company

PITTSBURGH & FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Carmell Therapeutics Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative medicine company today announced the execution of a definitive agreement and...

1 year ago - Business Wire

Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

NEW YORK & PITTSBURGH--(BUSINESS WIRE)--Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the successful co...

1 year ago - Business Wire

Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

NEW YORK--(BUSINESS WIRE)--Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a non-binding...

1 year ago - Business Wire